John Newman
Stock Analyst at Canaccord Genuity
(0.19)
# 4,679
Out of 5,090 analysts
960
Total ratings
39.4%
Success rate
-4.3%
Average return
Main Sectors:
Stocks Rated by John Newman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Reiterated: Buy | $152 | $120.39 | +26.26% | 5 | Oct 30, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Buy | $875 → $922 | $927.89 | -0.63% | 119 | Oct 28, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $132 | $88.17 | +49.71% | 33 | Oct 27, 2026 | |
| XNCR Xencor | Reiterated: Buy | $38 | $29.82 | +27.43% | 13 | Oct 27, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $7 | $0.7865 | +790.02% | 17 | Oct 26, 2026 | |
| RLAY Relay Therapeutics | Reiterated: Buy | $29 | $18.35 | +58.04% | 3 | Oct 26, 2026 | |
| TNGX Tango Therapeutics | Reiterated: Buy | $46 | $22.72 | +102.46% | 16 | Oct 23, 2026 | |
| MRKR Marker Therapeutics | Reiterated: Buy | $8 | $0.98 | +716.33% | 16 | Oct 20, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $50 | $21.07 | +137.30% | 17 | Oct 20, 2026 | |
| ATRA Atara Biotherapeutics | Reiterated: Buy | $13 | $8.01 | +62.30% | 93 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.18 | +1,086.44% | 39 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $3.42 | +426.32% | 34 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $20 | $2.62 | +663.36% | 5 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $8.50 | +241.18% | 2 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $8.33 | +200.12% | 13 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $14.04 | +49.57% | 30 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.00 | +800.00% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $1.77 | +1,142.94% | 69 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.67 | n/a | 18 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.4254 | n/a | 19 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $300 | $5.00 | n/a | 34 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $6.49 | n/a | 45 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $44 | $30.55 | n/a | 57 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $0.0005 | n/a | 24 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $353.04 | $20.78 | n/a | 2 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $23.26 | n/a | 1 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $13.15 | n/a | 25 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.67 | n/a | 12 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13.96 | $9.18 | n/a | 1 | Mar 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $0.5603 | n/a | 18 | Jun 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $6 | $1.12 | n/a | 18 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $37.41 | n/a | 17 | Jun 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $16.65 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $13.48 | n/a | 11 | Mar 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $7.51 | n/a | 12 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $60 | $0.6996 | n/a | 13 | Nov 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $15 | $1.44 | n/a | 4 | Oct 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $10.28 | n/a | 17 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $4.82 | n/a | 9 | Jul 26, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 | $28.52 | n/a | 1 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $2.44 | n/a | 1 | May 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $31.89 | n/a | 1 | May 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $884.74 | n/a | 1 | Mar 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $6 | $1.03 | n/a | 5 | Mar 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $201 | $215.98 | n/a | 5 | Mar 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $7.07 | n/a | 1 | Jan 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $9 | $11.03 | n/a | 3 | Oct 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $127 | $253.62 | n/a | 45 | Dec 20, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 | $3.50 | n/a | 2 | Mar 15, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $75.34 | n/a | 1 | Jun 10, 2009 |
Incyte
Oct 30, 2026
Reiterated: Buy
Price Target: $152
Current: $120.39
Upside: +26.26%
Regeneron Pharmaceuticals
Oct 28, 2026
Reiterated: Buy
Price Target: $875 → $922
Current: $927.89
Upside: -0.63%
BioNTech SE
Oct 27, 2026
Reiterated: Buy
Price Target: $132
Current: $88.17
Upside: +49.71%
Xencor
Oct 27, 2026
Reiterated: Buy
Price Target: $38
Current: $29.82
Upside: +27.43%
Compass Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $7
Current: $0.7865
Upside: +790.02%
Relay Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $29
Current: $18.35
Upside: +58.04%
Tango Therapeutics
Oct 23, 2026
Reiterated: Buy
Price Target: $46
Current: $22.72
Upside: +102.46%
Marker Therapeutics
Oct 20, 2026
Reiterated: Buy
Price Target: $8
Current: $0.98
Upside: +716.33%
Tyra Biosciences
Oct 20, 2026
Reiterated: Buy
Price Target: $50
Current: $21.07
Upside: +137.30%
Atara Biotherapeutics
Oct 14, 2026
Reiterated: Buy
Price Target: $13
Current: $8.01
Upside: +62.30%
Sep 30, 2026
Reiterated: Buy
Price Target: $14
Current: $1.18
Upside: +1,086.44%
Sep 29, 2026
Reiterated: Buy
Price Target: $18
Current: $3.42
Upside: +426.32%
Sep 9, 2026
Reiterated: Buy
Price Target: $23 → $20
Current: $2.62
Upside: +663.36%
Sep 1, 2026
Reiterated: Buy
Price Target: $29
Current: $8.50
Upside: +241.18%
Aug 13, 2026
Reiterated: Buy
Price Target: $25
Current: $8.33
Upside: +200.12%
Aug 11, 2026
Reiterated: Buy
Price Target: $21
Current: $14.04
Upside: +49.57%
Aug 6, 2026
Reiterated: Buy
Price Target: $9
Current: $1.00
Upside: +800.00%
Aug 6, 2026
Reiterated: Buy
Price Target: $22
Current: $1.77
Upside: +1,142.94%
Nov 12, 2024
Reiterated: Buy
Price Target: $10
Current: $3.67
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: $5
Current: $0.4254
Upside: n/a
Oct 1, 2024
Reiterated: Buy
Price Target: $6 → $300
Current: $5.00
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $43
Current: $6.49
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $52 → $44
Current: $30.55
Upside: n/a
Aug 17, 2021
Reiterated: Buy
Price Target: $7 → $3
Current: $0.0005
Upside: n/a
May 26, 2021
Reiterated: Buy
Price Target: $353.04
Current: $20.78
Upside: n/a
May 12, 2021
Reiterated: Buy
Price Target: $31
Current: $23.26
Upside: n/a
May 3, 2021
Reiterated: Buy
Price Target: $45
Current: $13.15
Upside: n/a
Mar 25, 2021
Reiterated: Buy
Price Target: $5
Current: $0.67
Upside: n/a
Mar 9, 2020
Reiterated: Buy
Price Target: $13.96
Current: $9.18
Upside: n/a
Jun 26, 2019
Reiterated: Buy
Price Target: $20
Current: $0.5603
Upside: n/a
Aug 13, 2018
Reiterated: Buy
Price Target: $31 → $6
Current: $1.12
Upside: n/a
Jun 27, 2017
Reiterated: Buy
Price Target: $8 → $5
Current: $37.41
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $10
Current: $16.65
Upside: n/a
Mar 1, 2017
Reiterated: Buy
Price Target: $12
Current: $13.48
Upside: n/a
Dec 30, 2016
Reiterated: Buy
Price Target: $10
Current: $7.51
Upside: n/a
Nov 9, 2016
Reiterated: Buy
Price Target: $6 → $60
Current: $0.6996
Upside: n/a
Oct 11, 2016
Reiterated: Buy
Price Target: $6 → $15
Current: $1.44
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $34
Current: $10.28
Upside: n/a
Jul 26, 2016
Reiterated: Buy
Price Target: $3
Current: $4.82
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $90
Current: $28.52
Upside: n/a
May 13, 2016
Reiterated: Buy
Price Target: $30
Current: $2.44
Upside: n/a
May 2, 2016
Reiterated: Buy
Price Target: $26
Current: $31.89
Upside: n/a
Mar 31, 2016
Reiterated: Buy
Price Target: $18
Current: $884.74
Upside: n/a
Mar 9, 2015
Reiterated: Hold
Price Target: $8 → $6
Current: $1.03
Upside: n/a
Mar 3, 2015
Reiterated: Buy
Price Target: $201
Current: $215.98
Upside: n/a
Jan 7, 2015
Initiated Coverage: Buy
Price Target: $24
Current: $7.07
Upside: n/a
Oct 7, 2014
Downgraded: Hold
Price Target: $40 → $9
Current: $11.03
Upside: n/a
Dec 20, 2011
Rated: Buy
Price Target: $127
Current: $253.62
Upside: n/a
Mar 15, 2010
Downgraded: Sell
Price Target: $5
Current: $3.50
Upside: n/a
Jun 10, 2009
Reiterated: Sell
Price Target: n/a
Current: $75.34
Upside: n/a